Literature DB >> 16891288

Resistant hypertension: diagnosis and management.

Dimitris P Papadopoulos1, Vasilios Papademetriou.   

Abstract

The incidence of resistant hypertension, the failure to reduce blood pressure below 140/90 mm Hg, despite the use of 3 antihypertensive medications at optimal doses including a diuretic, is estimated to be less than 5% of the hypertensive population. Resistant hypertension increases the risk of stroke, myocardial infarction, congestive heart failure, and renal failure. Evaluation of the patient with resistant hypertension should include 24-hour ambulatory blood pressure monitoring or home measurements and a limited search for secondary causes. Treatment should focus on optimizing the drug regimen in a logical way, based on the patient's comorbidities and tolerability. Long-acting, well-tolerated once-daily medications are preferred, and the regimen should include in sequence a diuretic, beta-blocker, angiotensin-converting enzyme/angiotensin receptor-blocker inhibitors, and a calcium-channel blocker. This article reviews the definitions and causes and provides specific recommendations for the evaluation and management of patients with this life-threatening condition.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16891288     DOI: 10.1177/1074248406289735

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol Ther        ISSN: 1074-2484            Impact factor:   2.457


  9 in total

Review 1.  Cardiovascular hypertensive emergencies.

Authors:  D P Papadopoulos; E A Sanidas; N A Viniou; V Gennimata; V Chantziara; I Barbetseas; T K Makris
Journal:  Curr Hypertens Rep       Date:  2015-02       Impact factor: 5.369

Review 2.  Clinical characteristics of resistant hypertension: the importance of compliance and the role of diagnostic evaluation in delineating pathogenesis.

Authors:  Jeanie Park; Vito Campese
Journal:  J Clin Hypertens (Greenwich)       Date:  2007-01       Impact factor: 3.738

3.  Resistant hypertension workup and approach to treatment.

Authors:  Anastasios Makris; Maria Seferou; Dimitris P Papadopoulos
Journal:  Int J Hypertens       Date:  2010-12-26       Impact factor: 2.420

4.  Common secondary causes of resistant hypertension and rational for treatment.

Authors:  Charles Faselis; Michael Doumas; Vasilios Papademetriou
Journal:  Int J Hypertens       Date:  2011-03-02       Impact factor: 2.420

Review 5.  Cardiovascular Hypertensive Crisis: Recent Evidence and Review of the Literature.

Authors:  Christos Varounis; Vasiliki Katsi; Petros Nihoyannopoulos; John Lekakis; Dimitris Tousoulis
Journal:  Front Cardiovasc Med       Date:  2017-01-10

Review 6.  Masked hypertension definition, impact, outcomes: a critical review.

Authors:  Dimitris P Papadopoulos; Thomas K Makris
Journal:  J Clin Hypertens (Greenwich)       Date:  2007-12       Impact factor: 3.738

7.  Evaluation and treatment of resistant or difficult-to-control hypertension.

Authors:  David Wojciechowski; Vasilios Papademetriou; Charles Faselis; Ross Fletcher
Journal:  J Clin Hypertens (Greenwich)       Date:  2008-11       Impact factor: 3.738

8.  Minoxidil for Treatment of Resistant Hypertension in Chronic Kidney Disease--A Retrospective Cohort Analysis.

Authors:  Heiko M Mundt; Matthias Matenaer; Alexander Lammert; Uwe Göttmann; Bernhard K Krämer; Rainer Birck; Urs Benck
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-06-01       Impact factor: 3.738

9.  Prevalence and predictors of resistant hypertension in a primary care setting: a cross-sectional study.

Authors:  Yook Chin Chia; Siew Mooi Ching
Journal:  BMC Fam Pract       Date:  2014-07-05       Impact factor: 2.497

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.